VERA
Vera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$35.89
+2.57%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-98.6%
Return on equity
-75.4%
Return on assets
-86.1%
Return on invested capital
0.00x
Asset turnover
-$338.7M
Cash from operations
$6.93
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026